Investor Goldman Capital Management Inc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Goldman Capital Management Inc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2016-02-22 13G CYRN / CYREN Ltd 1,628,000 2,092,131
2015-02-17 13G HILL / Dot Hill Systems Corp 4,093,317
2015-02-17 13G CXDO / Crexendo, Inc. 753,054
2015-01-07 13G FCRE / FC Global Realty Incorporated 1,050,099
2014-10-24 13G OPRX / OptimizeRx Corporation 1,532,394
2014-04-18 13G HPTO / hopTo Inc. 6,733,333
2014-04-03 13G CTHR / Charles & Colvard, Ltd. 1,344,494
2013-12-12 13G MATR / Mattersight Corp. 1,182,233
2013-12-12 13G XTNT / Xtant Medical Holdings, Inc. 1,500,000
2013-09-26 13G LOCMQ / Local Corp 2,809,700
2013-09-26 13G REFR / Research Frontiers Incorporated 1,179,000
2013-07-23 13G LOCMQ / Local Corp 2,440,527
2013-07-23 13G XTNT / Xtant Medical Holdings, Inc. 2,639,014
2013-04-22 13G LOCMQ / Local Corp 1,367,500
2013-04-01 13G DPDW / Deep Down Inc 845,000
2013-01-28 13G TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock) 622,000
2013-01-25 13G MOSY / Mosys Inc 1,218,398
2013-01-08 13G DPDW / Deep Down Inc 1,062,052
2013-01-08 13G LCUT / Lifetime Brands, Inc. 572,714
2012-12-05 13G JNP / Juniper Pharmaceuticals, Inc. 4,055,412
2012-04-16 13G/A PHMD / PhotoMedex, Inc. 467,726
2012-04-13 13G PHMD / PhotoMedex, Inc. 467,726
2012-01-27 13G DPDW / Deep Down Inc 13,411,034